Mahek R. Mattikop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahek R. Mattikop has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Mandati Santhosh Reddy
Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Karnataka, India
2 shared publications - Madiwalayya Shivakantayya Ganachari
Department of Pharmacy Practice, KLE College of Pharmacy Belagavi, KLE Academy of Higher Education & Research Belagavi, Karnataka, India
1 shared publication - Meganie Velosha Fernandes
Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, India
1 shared publication - Pratiksha Kini
Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, India
1 shared publication - Ramesh S. Koujalagi
Department of General Surgery, Jawaharlal Nehru Medical College, Belagavi, India
1 shared publication - Shreya S Kajave
Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Karnataka, India
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Korean Society of Acute Care Surgery in JOURNAL OF ACUTE CARE SURGERY
- Vol. 16 (1) , 60-64
Fournier gangrene mimicking epididymo-funiculitis in a 63-year-old man in India: a case report
Fournier gangrene (FG) is an uncommon but life-threatening condition characterized by rapidly spreading necrotizing fasciitis of the perianal, genital, or perineal regions and accounts for less than 0.02% of hospital admissions, with a reported fatality rate of 20% to 30%. Early diagnosis and prompt multidisciplinary management are essential for achieving optimal outcomes. A 63-year-old man presented with swelling in the right scrotal region. He underwent surgical incision and drainage followed by negative pressure wound therapy. Despite the severity of the presentation, the patient’s prognosis was favorable. This case highlights the risk of misdiagnosing FG in the outpatient setting when initial symptoms resemble benign scrotal conditions and underscores the importance of rapid intervention. The involvement of a clinical pharmacist may enhance patient care by supporting the implementation of an optimized treatment strategy for FG.
- 31 March 2026
- Published by Korean Society of Acute Care Surgery in JOURNAL OF ACUTE CARE SURGERY
- Vol. 16 (1) , 60-64
Open AccessFournier gangrene mimicking epididymo-funiculitis in a 63-year-old man in India: a case report
Fournier gangrene (FG) is an uncommon but life-threatening condition characterized by rapidly spreading necrotizing fasciitis of the perianal, genital, or perineal regions and accounts for less than 0.02% of hospital admissions, with a reported fatality rate of 20% to 30%. Early diagnosis and prompt multidisciplinary management are essential for achieving optimal outcomes. A 63-year-old man presented with swelling in the right scrotal region. He underwent surgical incision and drainage followed by negative pressure wound therapy. Despite the severity of the presentation, the patient’s prognosis was favorable. This case highlights the risk of misdiagnosing FG in the outpatient setting when initial symptoms resemble benign scrotal conditions and underscores the importance of rapid intervention. The involvement of a clinical pharmacist may enhance patient care by supporting the implementation of an optimized treatment strategy for FG.
- Open Access
- 8 January 2025
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 96 (1)
Addressing inhaler technique challenges in cognitively impaired chronic obstructive pulmonary disease patients: the impact of customized training programs
Individuals with chronic obstructive pulmonary disease (COPD) and cognitive impairment (CI) often face difficulties accurately administering inhalers, which are essential for managing their respiratory condition. Many elderly individuals make major errors that prevent proper medication administration. Maintaining proper inhaler use skills is critical in controlling COPD. Our goal was to examine and evaluate the inhaler use skills of CI patients with COPD during both the initial evaluation and subsequent appointments. The Respiratory Department of KLEs Dr. Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Belagavi, Karnataka, India, was the site of this prospective interventional study. Based on the Montreal Cognitive Assessment Scale (MoCA), a subset of patients with COPD exhibited mild CI. Patients exhibiting improper inhaler-using skills were detected, corrected, and trained. Inhaler techniques were reassessed immediately and at follow-up visits. The modified Medical Research Council scale score (mMRC), COPD Assessment Test (CAT) score, St. George Respiratory Questionnaire (SGRQ), and pulmonary function tests were reassessed. A total of 56 COPD and CI patients who had made at least one significant mistake when using an inhaler device were added to the study. The mean age was 66.89±9.85 years. When evaluated with MoCA, the mean score was 17.02±3.91. At baseline, the mean number of mistakes was 1.38±0.93, which decreased to 0.54±0.57 after face-to-face demonstration of correct inhaler techniques. Correlational analysis revealed MoCA scores were negatively associated with the number of mistakes (r=-0.344). At follow-up, the CAT score (25±5.61 vs. 18.48±5.24 p=0.001), SGRQ score (53.82±20.59 vs. 37.61±22.17 p=0.001), mMRC score (3.21±0.76 vs. 3.20±0.75 p=0.001), and forced expiratory volume in 1 second/forced vital capacity score (66.86±9.35 vs. 70.08±9.07 p=0.001) had significantly improved in patients demonstrating the correct technique. Pharmacist-led interventions demonstrated improvements in health-associated quality of life and therapeutic outcomes for individuals with COPD and CI. The study highlighted the importance of cognitive evaluation in routine COPD therapy, identifying potential impediments to effective therapy, and offering face-to-face presentations of inhaler techniques. The best inhalers and methods for COPD patients experiencing CI should be further investigated, according to the study.
- 8 January 2025
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 96 (1)
Open AccessAddressing inhaler technique challenges in cognitively impaired chronic obstructive pulmonary disease patients: the impact of customized training programs
Individuals with chronic obstructive pulmonary disease (COPD) and cognitive impairment (CI) often face difficulties accurately administering inhalers, which are essential for managing their respiratory condition. Many elderly individuals make major errors that prevent proper medication administration. Maintaining proper inhaler use skills is critical in controlling COPD. Our goal was to examine and evaluate the inhaler use skills of CI patients with COPD during both the initial evaluation and subsequent appointments. The Respiratory Department of KLEs Dr. Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Belagavi, Karnataka, India, was the site of this prospective interventional study. Based on the Montreal Cognitive Assessment Scale (MoCA), a subset of patients with COPD exhibited mild CI. Patients exhibiting improper inhaler-using skills were detected, corrected, and trained. Inhaler techniques were reassessed immediately and at follow-up visits. The modified Medical Research Council scale score (mMRC), COPD Assessment Test (CAT) score, St. George Respiratory Questionnaire (SGRQ), and pulmonary function tests were reassessed. A total of 56 COPD and CI patients who had made at least one significant mistake when using an inhaler device were added to the study. The mean age was 66.89±9.85 years. When evaluated with MoCA, the mean score was 17.02±3.91. At baseline, the mean number of mistakes was 1.38±0.93, which decreased to 0.54±0.57 after face-to-face demonstration of correct inhaler techniques. Correlational analysis revealed MoCA scores were negatively associated with the number of mistakes (r=-0.344). At follow-up, the CAT score (25±5.61 vs. 18.48±5.24 p=0.001), SGRQ score (53.82±20.59 vs. 37.61±22.17 p=0.001), mMRC score (3.21±0.76 vs. 3.20±0.75 p=0.001), and forced expiratory volume in 1 second/forced vital capacity score (66.86±9.35 vs. 70.08±9.07 p=0.001) had significantly improved in patients demonstrating the correct technique. Pharmacist-led interventions demonstrated improvements in health-associated quality of life and therapeutic outcomes for individuals with COPD and CI. The study highlighted the importance of cognitive evaluation in routine COPD therapy, identifying potential impediments to effective therapy, and offering face-to-face presentations of inhaler techniques. The best inhalers and methods for COPD patients experiencing CI should be further investigated, according to the study.